logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
6/28/2019 7:01:29 AM Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent For Moderate-to-Severe Atopic Dermatitis In Adolescents
6/21/2019 1:00:40 AM Regeneron, Sanofi: Phase 2 Proof-of-concept Trial Evaluating IL-33 Antibody REGN3500 Met Primary Endpoint
6/14/2019 7:02:16 AM Regeneron Announces Positive Early-stage Data For REGN1979 In Patients With R/R B-cell Non-Hodgkin Lymphoma
5/16/2019 7:08:58 AM Regeneron Pharma, Sanofi Say Positive Updated Data For Libtayo To Be Shared At ASCO Annual Meeting
5/7/2019 9:06:57 AM Regeneron And Sanofi Announce That EC Approve New Indication For Dupixent In Asthma
5/7/2019 6:32:20 AM Regeneron Q1 GAAP EPS $3.99 And Non-GAAP EPS $4.45
4/8/2019 7:01:41 AM Regeneron And Alnylam Collaborate To Discover, Develop And Commercialize New RNAi Therapeutics
3/13/2019 7:01:16 AM Regeneron And Sanofi To Present New Praluent Data At ACC.19